AU2003266621A8 - Medicinal composition for treatment for or prevention of visceral pain - Google Patents
Medicinal composition for treatment for or prevention of visceral painInfo
- Publication number
- AU2003266621A8 AU2003266621A8 AU2003266621A AU2003266621A AU2003266621A8 AU 2003266621 A8 AU2003266621 A8 AU 2003266621A8 AU 2003266621 A AU2003266621 A AU 2003266621A AU 2003266621 A AU2003266621 A AU 2003266621A AU 2003266621 A8 AU2003266621 A8 AU 2003266621A8
- Authority
- AU
- Australia
- Prior art keywords
- prevention
- treatment
- medicinal composition
- visceral pain
- visceral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002278550 | 2002-09-25 | ||
| JP2002-278550 | 2002-09-25 | ||
| PCT/JP2003/012262 WO2004029057A1 (en) | 2002-09-25 | 2003-09-25 | Medicinal composition for treatment for or prevention of visceral pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003266621A8 true AU2003266621A8 (en) | 2004-04-19 |
| AU2003266621A1 AU2003266621A1 (en) | 2004-04-19 |
Family
ID=32040429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003266621A Abandoned AU2003266621A1 (en) | 2002-09-25 | 2003-09-25 | Medicinal composition for treatment for or prevention of visceral pain |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2003266621A1 (en) |
| TW (1) | TW200418479A (en) |
| WO (1) | WO2004029057A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101003537A (en) * | 2006-01-17 | 2007-07-25 | 上海恒瑞医药有限公司 | Derivative in pyrrolopyridazine category, preparation method, and application |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL97931A0 (en) * | 1990-04-27 | 1992-06-21 | Byk Gulden Lomberg Chem Fab | Pyridazine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
| AU8712191A (en) * | 1990-10-15 | 1992-05-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New diazines |
| DK0609328T3 (en) * | 1991-10-25 | 1999-10-25 | Byk Gulden Lomberg Chem Fab | Pyrrolo-pyridazines with gastrointestinal protective effect |
| MX9602850A (en) * | 1994-01-19 | 1997-06-28 | Sankyo Co | DERIVATIVES OF PYRROLOPYRIDAZINE. |
| SE9704404D0 (en) * | 1997-11-28 | 1997-11-28 | Astra Ab | New compounds |
| DE19859231A1 (en) * | 1998-12-21 | 2000-06-29 | Kurt Heinz Bauer | Foaming antacid suspension tablets |
| TWI287014B (en) * | 1999-06-15 | 2007-09-21 | Sankyo Co | Optically active pyrrolopyridazine compound |
| TWI237695B (en) * | 1999-12-14 | 2005-08-11 | Joy Biomedical Corp | Helicobacter pylori antigens in blood |
| ATE361925T1 (en) * | 2000-02-10 | 2007-06-15 | Sankyo Co | PYRROLOPYRIDAZINE COMPOUNDS |
| JP2002068992A (en) * | 2000-08-25 | 2002-03-08 | Ito En Ltd | Eradicating agent for helicobacter pylori, and food, beverage or food additive having this eradicating effect |
| JP3387066B2 (en) * | 2000-12-14 | 2003-03-17 | 三共株式会社 | Anti-ulcer agent containing pyrrolopyridazine compound |
| JP2003119140A (en) * | 2001-08-08 | 2003-04-23 | Sankyo Co Ltd | Pharmaceuticals containing pyrrolopyridazine compounds |
-
2003
- 2003-09-25 AU AU2003266621A patent/AU2003266621A1/en not_active Abandoned
- 2003-09-25 WO PCT/JP2003/012262 patent/WO2004029057A1/en not_active Ceased
- 2003-09-25 TW TW092126426A patent/TW200418479A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004029057A1 (en) | 2004-04-08 |
| AU2003266621A1 (en) | 2004-04-19 |
| TW200418479A (en) | 2004-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003290548A8 (en) | Prevention and treatment of synucleinopathic disease | |
| ZA200703601B (en) | Medicaments for the treatment or prevention of fibriotic diseases | |
| TWI347188B (en) | Treatment and prevention of osteoporosis | |
| AU2003278775A8 (en) | Porifera-based therapeutic compositions for treating and preventing skin diseases | |
| AU2002248319A1 (en) | Pharmaceutical composition for the prevention and treatment of scar tissue | |
| AU2002323823A1 (en) | Medicament for prevention and treatment of fracture and osteoporosis | |
| GB0213869D0 (en) | The treatment of pain | |
| AU2003237969A8 (en) | Pharmaceutical composition comprising calcium channel blockers for the treatment of pain | |
| GB0211295D0 (en) | Treatment of pain | |
| HUP0300402A3 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them | |
| IL166062A0 (en) | Compositions and methods for therapeutic treatment | |
| HUP0303779D0 (en) | Pharmaceutical compositions for the treatment of sclerosis multiplex | |
| AU2003266621A8 (en) | Medicinal composition for treatment for or prevention of visceral pain | |
| TWI345980B (en) | Pharmaceutical compositions for preventing or treating injuries of brain tissue | |
| HUP0104968D0 (en) | Transdermal pharmaceutical composition containing aspirine for the treatment of sclerosis | |
| PL367634A1 (en) | Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases | |
| GB9904252D0 (en) | Composition for the treatment of pain | |
| AU2003277298A8 (en) | Pharmaceutical compositions for treatment of parkinson's disease | |
| GB0100092D0 (en) | Treatment of degenerative diseases | |
| PL354698A1 (en) | Pharmaceutical compound for prevention or treatment of self-immunization based diseases | |
| GB0222505D0 (en) | Treatment of pain | |
| GB0325957D0 (en) | The treatment of pain | |
| GB0310463D0 (en) | Therapeutic agents for the treatment of bone conditions | |
| GB0325259D0 (en) | Therapeutic agents for the treatment of bone conditions | |
| SI1610785T1 (en) | Pharmaceutical combination for the treatment of spasticity and/or pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |